Skip to content
Taiwan
-
Bora Group expands US biologics footprint with US$127.5M MacroGenics CDMO acquisition
The acquisition includes MacroGenics’ biologics drug substance manufacturing facility in Rockville, Maryland, as well as a warehousing center in Frederick, Maryland, located about 30 miles away.
-
BioDuro expands API production to Taiwan through new joint venture with Cenra
The venture aims to deliver comprehensive active pharmaceutical ingredient (API) services, covering everything from initial development stages through full-scale commercial production.